Table 1.
Baseline Characteristics of the Study Population
| Control N:30 | STEMI N:25 | NSTEMI N:16 | USAP N:29 | SAP N:34 | p | |
|---|---|---|---|---|---|---|
| Age | 54.4±12.5 | 58.4±9.8 | 68.1±12.1 | 59.7±10.8 | 63.7±9.4 | <0.001* |
| Gender (F/M) | 17/13(56%) | 5/20(20%) | 9/7(56%) | 9/20(31%) | 14/20(41%) | 0.017** |
| Weight | 77.9±12.5 | 79.5±10.5 | 75.3±12.7 | 79.2±10.7 | 85.1±13.6 | 0.058 |
| Height | 163.3±9.2 | 167.4±8.1 | 162.2±7.5 | 166.5±8.6 | 165.6±9.8 | 0.262 |
| BMI | 29.4±5.2 | 28.4±3.4 | 28.7±5.2 | 28.6±4.1 | 31.2±5.7 | 0.146 |
| Met S | 12 (40.0%) | 13 (52.0%) | 11 (68.8%) | 13 (44.8%) | 26 (76.5%) | 0.021*** |
| HT | 16 (53.3%) | 10 (40.0%) | 11 (68.8%) | 13 (44.8%) | 25 (73.5%) | 0.051 |
| DM | 6 (20.0%) | 8 (32.0%) | 6 (37.5%) | 6 (20.7%) | 17 (50.0%) | 0.062 |
| Glu (mg/dL) | 92(78-300) | 126(80-270) | 130(80-300) | 96(58-161) | 115(63-280) | <0.001† |
| FH | 10 (33.3%) | 11 (44.0%) | 6 (37.5%) | 9 (31.0%) | 7 (20.6%) | 0.414 |
| HPL | 14 (46.7%) | 11 (44.4%) | 8 (50.0%) | 13 (44.8%) | 21 (61.8%) | 0.612 |
| Smoking | 10 (33.3%) | 16 (64.0%) | 7 (43.8%) | 16 (55.2%) | 14 (41.2%) | 0.167 |
| EF (%) | 67 (30-74) | 42.5 (35-57) | 47.5 (28-68) | 66 (20-70) | 66 (45-71) | <0.001†† |
| Hb (g/dL) | 14.1±1.1 | 14.2±1.6 | 13.5±1.9 | 14.2±1.8 | 14.2±1.2 | 0.487 |
| Ischemic ECG | 7 (23%) | 25 (100%) | 8 (50%) | 13 (44.8%) | 6 (17.6%) | <0.001‡ |
Basal characteristics of the study population. BMI: body mass index, Met S: metabolic syndrome, DM: diabetes mellitus, HT: hypertension, FH: family history of atherosclerotic coronary artery disease, EF: ejection fraction, Hb: hemoglobin, Glu: fasting blood glucose. For p values
*
control-Non ST Elevation MI (NSTEMI)
**
ST Elevation MI (STEMI) - NSTEMI
***
control-Stable Angina Pectoris (SAP)
†
control-STEMI/NSTEMI
††
control-STEMI/NSTEMI
‡
control-STEMI/NSTEMI.